Snowball logo
logo
IX1_logo

IDEXX Laboratories Inc

€509.60+€8.80  (1.76%)
Estimate
P/E
41.8
EPS
12.2
Beta
1.548
Growth
Revenue, YoY
12.59%
Net income, YoY
18.19%
FCF, YoY
117.09%
About the company
Ticker
IX1
ISIN
US45168D1046
Country
United States of America
Sector (GICS)
Healthcare
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Frequently asked questions

What sector does IDEXX Laboratories Inc (IX1) operate in?

IDEXX Laboratories Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is IDEXX Laboratories Inc (IX1) current stock price?

As of the latest data, IDEXX Laboratories Inc stock price is €509.60, with a previous close of €500.80. IDEXX Laboratories Inc gained €8.80 in the last trading session, representing a 1.76% increase.

What is IDEXX Laboratories Inc (IX1) current market capitalization?

IDEXX Laboratories Inc market cap is approximately 40.20 billion.

What is IDEXX Laboratories Inc (IX1) Earnings Per Share (EPS)?

The trailing EPS is €12.20.

What is IDEXX Laboratories Inc (IX1) Price-to-Earnings (P/E) ratio?

IDEXX Laboratories Inc current P/E ratio is 41.77.

What is IDEXX Laboratories Inc (IX1) EBITDA?

IDEXX Laboratories Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 410.13 million.

Does IDEXX Laboratories Inc (IX1) pay dividends?

No. IDEXX Laboratories Inc does not pay a dividend.

When is IDEXX Laboratories Inc (IX1) next earnings report?

IDEXX Laboratories Inc is expected to release its next earnings report on September 30, 2026.

What is IDEXX Laboratories Inc (IX1) beta (volatility) score?

IDEXX Laboratories Inc has a beta of 1.548, suggesting it is more volatile than the market.